Associate Vice-President and GM of Incyte’s Chris White discusses Most Favoured Nation pricing impacts, drug access and reimbursement, and wildly authentic leadership. Get full access to NPC Healthbiz Weekly at <a href="https://healthbiz.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4">healthbiz.substack.com/subscribe</a>

Associate Vice-President and GM of Incyte’s Chris White discusses Most Favoured Nation pricing impacts, drug access and reimbursement, and wildly authentic leadership. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Associate Vice-President and GM of Incyte’s Chris White discusses Most Favoured Nation pricing impacts, drug access and reimbursement, and wildly authentic leadership. Get full access to NPC Healthbiz Weekly at <a href="https://healthbiz.substack.com/subscribe?utm_medium=podcast&amp;utm_campaign=CTA_4" rel="noopener noreferrer">healthbiz.substack.com/subscribe</a>

S16 E04 Bringing Innovative Therapies to Canada

Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry. <a href="https://healthbiz.substack.com?utm_medium=podcast">healthbiz.substack.com</a>

Science

Life Sciences

Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry. healthbiz.substack.com

Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry. <a href="https://healthbiz.substack.com?utm_medium=podcast" rel="noopener noreferrer">healthbiz.substack.com</a>

Share S16 E04 Bringing Innovative Therapies to Canada

Sign up to save your podcasts

S16 E04 Bringing Innovative Therapies to Canada

S16 E04 Bringing Innovative Therapies to Canada